MET exon 14 Mutations Encode a Hyperactive Kinase and Therapeutic Target in Lung Adenocarcinoma

被引：0

作者：

Peled, Nir ^{[1
]}

Lu, Xinyuan ^{[2
]}

Greer, John ^{[2
]}

Wu, Wei ^{[2
]}

Choi, Peter ^{[3
]}

Berger, Alice ^{[3
]}

Hann, Byron ^{[2
]}

Meyerson, Matthew ^{[4
,5
]}

Collisson, Eric ^{[2
]}

机构：

[1] Rabin Med Ctr, Tel Aviv, Israel

[2] UCSF, San Francisco, CA USA

[3] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA

[4] Broad Inst Harvard & Mit, Dana Farber Canc Inst, Boston, MA USA

[5] Massachusetts Gen Hosp, Boston, MA 02114 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

MET; Resistance; Targeted therapy; Mouse model;

D O I：

10.1016/j.jtho.2016.11.1323

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.03b042

引用

页码：S961 / S961

页数：1

共 50 条

[41] Epidemiological characteristics and therapeutic advances of EGFR exon 20 insertion mutations in non-small cell lung cancer [J].

Pan, Binyang ;

Liang, Jiaqi ;

Shi, Haochun ;

Rao, Kungeng ;

Guo, Weigang ;

Zhan, Cheng .

THORACIC CANCER, 2023, 14 (33) :3247-3258

[42] High MET Overexpression Does Not Predict the Presence of MET Exon 14 Splice Mutations in NSCLC: Results from the IFCT Predict.amm Study [J].

Baldacci, S. ;

Figeac, M. ;

Antoine, M. ;

Descarpentries, C. ;

Kherrouche, Z. ;

Jamme, P. ;

Copin, M. ;

Tulasne, D. ;

Nanni, I. ;

Beau-Faller, M. ;

Melaabi, S. ;

Levallet, G. ;

Quoix, E. ;

Moro-Sibilot, D. ;

Friard, S. ;

Missy, P. ;

Barlesi, F. ;

Cadranel, J. ;

Cortot, A. B. .

JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) :S851-S851

[43] Combination Therapy With MET Tyrosine Kinase Inhibitor and EGFR Tyrosine Kinase Inhibitor in Patients With MET-Overexpressed EGFR-Mutant Lung Adenocarcinoma [J].

Wu, Jia-Jun ;

Zheng, Zhe-Rong ;

Lo, Tse-Hsien ;

Chu, Cheng-Hsiang ;

Chen, Kun-Chieh ;

Chang, Gee-Chen .

JTO CLINICAL AND RESEARCH REPORTS, 2025, 6 (06)

[44] Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutation [J].

Takamori, Shinkichi ;

Seto, Takashi ;

Yamaguchi, Masafumi ;

Kinoshita, Fumihiko ;

Fujishita, Takatoshi ;

Ito, Kensaku ;

Toyozawa, Ryo ;

Shoji, Fumihiro ;

Okamoto, Tatsuro .

FRONTIERS IN ONCOLOGY, 2022, 12

[45] High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study [J].

Baldacci, Simon ;

Figeac, Martin ;

Antoine, Martine ;

Descarpentries, Clotilde ;

Kherrouche, Zoulika ;

Jamme, Philippe ;

Copin, Marie-Christine ;

Tulasne, David ;

Nanni, Isabelle ;

Beau-Faller, Michele ;

Melaabi, Samia ;

Levallet, Guenaelle ;

Quoix, Elisabeth ;

Moro-Sibilot, Denis ;

Friard, Sylvie ;

Missy, Pascale ;

Barlesi, Fabrice ;

Cadranel, Jacques ;

Cortot, Alexis B. .

JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (01) :120-124

[46] Savolitinib conferred sensitivity in a patient with D1228H mutation-induced capmatinib-resistant MET exon 14 skipping mutated lung adenocarcinoma [J].

Li, Xiuzhen ;

Lu, Yuefei ;

Zhao, Jie ;

Yu, Yinghui ;

Tian, Heshen ;

Zhu, Hao ;

Li, Wen ;

Xia, Yang ;

Chen, Laijuan .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (08)

[47] Non-small-cell lung cancer: how to manage MET exon 14 skipping mutant disease [J].

Blaquier, Juan Bautista ;

Recondo, Gonzalo .

DRUGS IN CONTEXT, 2022, 11

[48] Spotlight on Tepotinib and Capmatinib for Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation [J].

Brazel, Danielle ;

Zhang, Shannon ;

Nagasaka, Misako .

LUNG CANCER-TARGETS AND THERAPY, 2022, 13 :33-45

[49] MET Exon 14 Variants in Non-Small Cell Lung Carcinoma: Prevalence, Clinicopathologic and Molecular Features [J].

Yuan, Lisi ;

Mehrotra, Harshita ;

He, Xin ;

Bosler, David .

JOURNAL OF MOLECULAR PATHOLOGY, 2023, 4 (01) :46-56

[50] The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma [J].

Alvarez, Hector ;

Montgomery, Elizabeth A. ;

Karikari, Collins ;

Canto, Marcia ;

Dunbar, Kerry B. ;

Wang, Jean S. ;

Feldmann, Georg ;

Hong, Seung-Mo ;

Haffner, Michael C. ;

Meeker, Alan K. ;

Holland, Sacha J. ;

Yu, Jiaxin ;

Heckrodt, Thilo J. ;

Zhang, Jing ;

Ding, Pingyu ;

Goff, Dane ;

Singh, Rajinder ;

Carlos Roa, Juan ;

Marimuthu, Arivusudar ;

Riggins, Gregory J. ;

Eshleman, James R. ;

Nelkin, Barry D. ;

Pandey, Akhilesh ;

Maitra, Anirban .

CANCER BIOLOGY & THERAPY, 2010, 10 (10) :1009-1018

← 1 2 3 4 5 →